Genetic Predisposition for Multiple Metabolic Syndrome. Part. 2. Candidate Genes for TypeII Diabetes Mellitus
Authors:
J. Šobra; R. Češka
Authors‘ workplace:
III. interní klinika 1. LF UK a VFN, Praha
Published in:
Čas. Lék. čes. 1999; : 70-74
Category:
Overview
The author presents a review on candidate genes of proteins involved in the metabolism of glukose, lipids andother metabolites (glucose carriers, insulin receptors, proinsulin, glucokinase, amyline, glycogen synthase).One of the main causes of enhanced atherogenesis in patients with type II diabetes (NIDDM) are marked geneticallyconditioned deviations of the lipid, lipoprotein and apolipoprotein metabolism. In the metabolic dyshomeostasis ofmultiple metabolic syndrome participate in the process of atherogenesis also: isoforms of apolipoprotein E4, isoformsof apolipoprotein A-IV-1/1, hyperuricaemia, raised levels of the plasminogen activator inhibitor 1 (PAI-1),hyperfibrinogenaemia, hyperhomocysteinaemia and other metabolites (cytokines, endothelin etc.). Patients with agreated genetic sensitivity manifest diabetes sooner and more intensely and die at a younger age in particular fromcardiovascular disease, but also on account of a higher incidence of tumours diseases.
Key words:
candidate genes for type II diabetes mellitus, multiple metabolic syndrome, atherogenesis, geneticepidemiology, insulin resistance.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Talc - Standard Medicament in the Treatment of Malignant Pleural Effusion
- Budesonide (Turbuhaler), 400 mg/day, is at Least as Effective as a DoubleDose of Beclomethasone (MDI) in Patients with Mild to Medium Severe Bronchial Asthma
- Health Needs Assessment. Part 2. Need for Health and Need for Health Care
- Development of European Medicine up to Vesalius (16th century)